
The study investigates the potential of the brain in managing type 1 diabetes
A research article published in the Journal of Clinical Investigation indicates that the brain may serve as a target for novel treatments for type 1 diabetes, potentially enhancing insulin management. Researchers discovered that diabetic ketoacidosis (DKA) can be addressed with the hormone leptin, even without the presence of insulin. DKA arises when the body cannot…